Study: PET and SPECT are useful in imaging IGF-1R

04/20/2010 | AuntMinnie.com (free registration)

Dutch researchers using PET and SPECT said the imaging methods allowed them to successfully and noninvasively visualize the insulinlike growth factor 1 receptor among animal subjects with triple-negative breast cancer. Being able to image the receptor could improve patient selection from the triple-negative breast cancer patient population for targeted treatment using IGF-1R antibodies, an expert said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA